Last reviewed · How we verify
DP CD8 TIL
At a glance
| Generic name | DP CD8 TIL |
|---|---|
| Sponsor | AgonOx, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DP CD8 TIL CI brief — competitive landscape report
- DP CD8 TIL updates RSS · CI watch RSS
- AgonOx, Inc. portfolio CI